mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.098 |
0.003 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
KIN001-244 |
GDSC1000 |
pan-cancer |
AAC |
-0.091 |
0.004 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.004 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
TL-1-85 |
GDSC1000 |
pan-cancer |
AAC |
-0.085 |
0.005 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.15 |
0.006 |